Микоплазмозы и хламидиозы – современный взгляд

1. Baseman JB, Lange M, Criscimagna NL et al. Interplay between mycoplasmas and host target cells. Micr Pathog 1995; 19 (2): 105–16.
2. Гамова Н.А., Гончарова С.А. Обнаружение с помощью реакции агрегатагглютинации антигенов различных биоваров Ureaplasma urealyticum в сыворотке крови пациентов с воспалительными заболеваниями урогенитального тракта и нарушениями репродуктивной функции. Клин. лаб. диагн. 2003; 4: 46–8.
3. Cattean B, Dlaporte E, Hachulla E et al. Infection a mycjplasme avec syndrome de Stevans–Johnson et anticorps antiphospholipides: a propos de deuxeas. Rev Med Interne 1995; 16: 10–4.
4. Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 1993; 17 (Suppl. 1): S37–46.
5. Grau O, Slizewicz B, Tuppin P et al. Association of Mycoplasma penetrans with immunodeficiency virus infection. J Infect Dis 1995; 172: 672–81.
6. Johnson S, Sidebottom D, Bruckner F, Collins D. Identification of Mycoplasma fermentans in synovinal fluid samples fr om arthritis patients with inflammatory disease. J Clin Microbiol 2000; 38: 90–3.
7. Kong F, Ma Z, James G et al. Species identification and subtyping of ureaplasma parvum and Ureaplasma urealyticum using PCR-based assays. J Clin Microbiol 2000; 38 (3): 1175–9.
8. Nicolson GL, Nasralla M, Nicolson NL. The pathogenesis and treatment of mycoplasmal infections. Antimicrob Infect Dis Newsl 1999; 17: 81–8.
9. Snowden N, Wilson PB, Longson M et al. Antiphospholipid antibodies and Mycoplasma pneumoniae infection. Postgrad Med J 1990; 66: 356–62.
10. Garth L, Nicolson PhD, Marwan Y et al. Evidence for bacterial (Mycoplasma, Chlamydia) and Viral (HHV-6) coinfectionsi in chronic fatique syndrome patients. J Chronic fatique Syndrome 2003; 11 (2): 7–20.
11. Бородин А.М., Королева Е.Б., Хватова С.В. Диагностика внебольничной пневмонии микоплазменной и хламидийной этиологии методом ПЦР в закрытых коллективах. Клин. лаб. диагн. 2005; 2: 51–2.
12. Димов Д., Жутев И., Райчев Р. и др. Постреспираторный реактивный артрит – этиология, клинико-лабораторная характеристика и ранний прогноз. Тер. арх. 2001; 73 (12): 65–8.
13. Руководство по инфекционным болезням. Под. ред. Ю.В.Лобзина, СПб.: Фолиант, 2000.
14. Чураков А.А., Куличенко А.Н., Казакова Е.С. и др. К вопросу о лабораторной диагностике урогенитального хламидиоза. Клин. лаб. диагн. 2005; 2: 43–7.
15. Kennedy JR. Reactive arthritis: The result of an anti-idiotypic immune response to a bacterial lipopolysaccharide antigen wh ere the idiotype has the immunological appearance of a synovial antigen. Med Hypotheses 2000; 54: 5: 723–5.
16. MacMillan S, McKenzic H, Flett G et al. Which women should be tested for Chlamydia rachomatis? Br J Obstet Gynaecol 2000; 107: 1088–93.
17. Wong Y, Gallagher P, Ward M. Chlamydia pneumoniae and atherosclerosis. Heart 1999; 81 (3): 232–8.
18. Grunlee JE, Rose JW. Semin Neurol 2000; 20: 375–86.
19. Sharma S, Broussean R, Kasatiya S. Detection and confirmation of Mycoplasma pneumoniae in urogenital specimens by PCR. J Clin Microbiol 1988; 36 (1): 277–80.
20. Viscardi RM, Kaplan J, Lovchik JC et al. Characterization of murine model of Ureaplasma urealyticum pneumonia. Infect and Immun 2002; 70 (10): 5721–9.
21. Vittecoq O, Schaeverbeke T, Farve S et al. Molecular diagnosis of Ureaplasma urealyticum in immunocjmpetent patient with destructive reactive polyarthritis. Arthritis Rheum 1997; 11 (40): 2084–9.
22. Tanaka H, Abe S, Tamura H. Pathological changes by the imbalance of host T-helper lymphocyte subset in Mycoplasma pulmonis pneumonia of mice. Kansenshogaku Zasshi 1998; 4 (72): 342–6.
23. Daian CM, Wolff AH, Bielory L. The role of atypical organisms in asthma. Allergy and Asthma Proc 2000; 21: 107–11.
24. Koh YY, Park Y, Lee HJ et al. Pediatrics 2001; 3 (107): E39.
25. Аl-Daccak R, Mehindate K, Hebert J et al Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line. Infect Immune 1994; 6 (62): 2409–16.
26. Buslau M, Kappus R, Gerlach D et al. Streptococcal and staphylococcal superantigens (ETA, SEB): presentation by human epidermal cell and induction of autologious T-cell proliferation in vitro. Acta Derm Venerol (Stockh) 1993; 73: 94–6.
27. Gjertsson I, Foster S, Tarkowski A. Polarization of cytokine response in B- and T-lymphocytes during staphylococcus aureus infection. Microb Pathog 2003; 3 (35): 119–24.
28. Ахапкина И.Г. Частота выявления антител против антигенов Mycoplasma pneumoniae в сыворотках пациентов аллергологического центра. Клин. лаб. диагн. 2006; 1: 41–2.
29. Normann E, Gnarpe J, Gnarpe H et al. Chlamydia pneumoniae is a commn finding in young children with respiratory tract infections. Acta Paediatrica 1998; 87: 23–7.
30. Wenzel RP, Craven RB, Davies JA et al. Protective efficacy of an inactivated Mycoplasma pneumoniae vaccine. J Infect Dis 1977; 136: S204–7.
31. Страйер Л. Биохимия. В 3 т. Т. 3. Пер. с англ. М.: Мир, 1985.
32. Sandoz KM, Rockey DD. Antibiotic resistance in Chlamydiae. Future Microbiol 2010; 9 (5): 1427–42.

И.Г.Ахапкина 

НИИ вакцин и сывороток им. И.И.Мечникова РАМН, Москва